2/27
07:22 pm
jazz
Jazz Pharmaceuticals' CBD Drug Hits $1B: Time to Buy the Stock? [Yahoo! Finance]
Neutral
Report
Jazz Pharmaceuticals' CBD Drug Hits $1B: Time to Buy the Stock? [Yahoo! Finance]
2/27
09:16 am
jazz
Jazz Pharmaceuticals plc (JAZZ) Jumps Nearly 30% on Strong Q3 and Cancer Drug Trial Progress [Yahoo! Finance]
Low
Report
Jazz Pharmaceuticals plc (JAZZ) Jumps Nearly 30% on Strong Q3 and Cancer Drug Trial Progress [Yahoo! Finance]
2/27
08:44 am
jazz
Jazz Pharmaceuticals (JAZZ) is now covered by Barclays PLC. They set an "overweight" rating and a $224.00 price target on the stock.
Low
Report
Jazz Pharmaceuticals (JAZZ) is now covered by Barclays PLC. They set an "overweight" rating and a $224.00 price target on the stock.
2/26
03:27 am
jazz
A Look At Jazz Pharmaceuticals (JAZZ) Valuation After Record Quarter And 2026 Guidance [Yahoo! Finance]
Medium
Report
A Look At Jazz Pharmaceuticals (JAZZ) Valuation After Record Quarter And 2026 Guidance [Yahoo! Finance]
2/26
02:42 am
jazz
Jazz Pharmaceuticals plc Q4 2025 Earnings Call Summary [Yahoo! Finance]
Medium
Report
Jazz Pharmaceuticals plc Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/25
04:57 pm
jazz
Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why [Yahoo! Finance]
Medium
Report
Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why [Yahoo! Finance]
2/25
10:58 am
jazz
Jazz Pharmaceuticals (JAZZ) had its price target raised by Royal Bank Of Canada from $191.00 to $195.00. They now have an "outperform" rating on the stock.
Low
Report
Jazz Pharmaceuticals (JAZZ) had its price target raised by Royal Bank Of Canada from $191.00 to $195.00. They now have an "outperform" rating on the stock.
2/25
10:46 am
jazz
Jazz Pharmaceuticals (JAZZ) had its price target raised by Morgan Stanley from $225.00 to $226.00. They now have an "overweight" rating on the stock.
Medium
Report
Jazz Pharmaceuticals (JAZZ) had its price target raised by Morgan Stanley from $225.00 to $226.00. They now have an "overweight" rating on the stock.
2/25
10:24 am
jazz
Jazz Pharmaceuticals (JAZZ) had its price target raised by Wells Fargo & Company from $235.00 to $250.00. They now have an "overweight" rating on the stock.
Low
Report
Jazz Pharmaceuticals (JAZZ) had its price target raised by Wells Fargo & Company from $235.00 to $250.00. They now have an "overweight" rating on the stock.
2/25
08:03 am
jazz
Jazz Pharmaceuticals (JAZZ) had its price target raised by Bank of America Corporation from $263.00 to $275.00. They now have a "buy" rating on the stock.
Medium
Report
Jazz Pharmaceuticals (JAZZ) had its price target raised by Bank of America Corporation from $263.00 to $275.00. They now have a "buy" rating on the stock.
2/25
12:58 am
jazz
Jazz Pharmaceuticals plc (JAZZ) Q4 2025 Earnings Call Transcript [Seeking Alpha]
High
Report
Jazz Pharmaceuticals plc (JAZZ) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/24
04:30 pm
jazz
Jazz Pharmaceuticals (NASDAQ:JAZZ) Surprises With Q4 CY2025 Sales [Yahoo! Finance]
Medium
Report
Jazz Pharmaceuticals (NASDAQ:JAZZ) Surprises With Q4 CY2025 Sales [Yahoo! Finance]
2/24
04:05 pm
jazz
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2025 Financial Results and Provides 2026 Financial Guidance
High
Report
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2025 Financial Results and Provides 2026 Financial Guidance
2/24
04:05 pm
jazz
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2025 Financial Results and Provides 2026 Financial Guidance
High
Report
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2025 Financial Results and Provides 2026 Financial Guidance
2/17
04:39 pm
jazz
Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences [Yahoo! Finance]
2/17
04:15 pm
jazz
Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences
Low
Report
Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences
2/17
04:15 pm
jazz
Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences
Low
Report
Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences
2/15
07:12 pm
jazz
Is Jazz Pharmaceuticals (JAZZ) Pricing Misaligned With DCF And Sales-Based Valuation Signals? [Yahoo! Finance]
Low
Report
Is Jazz Pharmaceuticals (JAZZ) Pricing Misaligned With DCF And Sales-Based Valuation Signals? [Yahoo! Finance]
2/14
07:09 pm
jazz
Jazz Pharmaceuticals CEO Sets Long Term Vision For Growth And Execution [Yahoo! Finance]
Low
Report
Jazz Pharmaceuticals CEO Sets Long Term Vision For Growth And Execution [Yahoo! Finance]
2/10
04:33 pm
jazz
Jazz Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Tuesday, February 24, 2026 [Yahoo! Finance]
Low
Report
Jazz Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Tuesday, February 24, 2026 [Yahoo! Finance]
2/10
04:15 pm
jazz
Jazz Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Tuesday, February 24, 2026
Low
Report
Jazz Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Tuesday, February 24, 2026
2/10
04:15 pm
jazz
Jazz Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Tuesday, February 24, 2026
Low
Report
Jazz Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Tuesday, February 24, 2026
2/10
01:27 am
jazz
Columbia Disciplined Value Fund Q4 2025 Commentary [Seeking Alpha]
Low
Report
Columbia Disciplined Value Fund Q4 2025 Commentary [Seeking Alpha]
2/3
07:13 am
jazz
Truist Securities Raises Jazz Pharmaceuticals (JAZZ) Price Target After HERIZON-GEA Trial [Yahoo! Finance]
Low
Report
Truist Securities Raises Jazz Pharmaceuticals (JAZZ) Price Target After HERIZON-GEA Trial [Yahoo! Finance]
1/31
03:52 pm
jazz
Is Jazz Pharmaceuticals (JAZZ) Offering An Opportunity After Recent Share Price Pullback [Yahoo! Finance]
Medium
Report
Is Jazz Pharmaceuticals (JAZZ) Offering An Opportunity After Recent Share Price Pullback [Yahoo! Finance]